Open Access Repository

Humanity cannot afford a COVID‑19 patent battle


Downloads per month over past year

Nicol, D ORCID: 0000-0002-6553-2839 and Nielsen, J ORCID: 0000-0002-3005-0047 2020 , 'Humanity cannot afford a COVID‑19 patent battle' , Australian Academy of Science .

PDF (Final published version)
140180 - Humani...pdf | Download (2MB)

| Preview


The development of vaccines and therapeutics for COVID-19 requires a concerted global commitment to share research.Global research effort is usually highly competitive and undertaken by diverse parties. In the COVID-19 context, this may result in discrepancy between the amount of public funding available and the cost of developing effective vaccines.Intellectual property rights (particularly patents) on the technology behind vaccines can encourage innovation and safeguard investment in research and development. However, they can slow down development. Finding the right balance and coordinating a rapid response to this pandemic is vital.The COVID-19 pandemic has seen Australia, and other countries, committing promptly to contributing toward a shared research and funding effort.

Item Type: Article
Authors/Creators:Nicol, D and Nielsen, J
Keywords: Intellectual property, COVID, patents, compulsory licensing, public health, licensing
Journal or Publication Title: Australian Academy of Science
Publisher: Australian Academy of Science
ISSN: 1031-9204
Copyright Information:

© 2020 Nicol and Nielsen. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License(, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page